SG Americas Securities
TEVA icon

SG Americas Securities’s Teva Pharmaceuticals TEVA Stock Holding History

SG Americas Securities’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$43.4M Buy
1,282,256
+501,738
+64% +$16.7M 0.02% 382
2026
Q1 		$23.5M Buy
780,518
+545,601
+232% +$17.6M 0.03% 485
2025
Q4 		$7.33M Sell
234,917
-483,985
-67% -$11.9M 0.01% 918
2025
Q3 		$14.5M Buy
718,902
+259,122
+56% +$4.55M 0.05% 252
2025
Q2 		$7.71M Buy
459,780
+121,881
+36% +$1.97M 0.03% 364
2025
Q1 		$5.19M Sell
337,899
-81,061
-19% -$1.45M 0.02% 455
2024
Q4 		$9.23M Sell
418,960
-209,550
-33% -$3.81M 0.04% 235
2024
Q3 		$11.3M Sell
628,510
-22,974
-4% -$402K 0.04% 253
2024
Q2 		$10.6M Buy
651,484
+41,077
+7% +$633K 0.06% 317
2024
Q1 		$8.61M Buy
610,407
+65,529
+12% +$826K 0.04% 400
2023
Q4 		$5.69M Buy
544,878
+131,043
+32% +$1.22M 0.05% 321
2023
Q3 		$4.22M Buy
413,835
+212,761
+106% +$1.98M 0.05% 358
2023
Q2 		$1.51M Buy
201,074
+28,101
+16% +$228K 0.01% 866
2023
Q1 		$1.53M Buy
172,973
+13,890
+9% +$137K 0.02% 832
2022
Q4 		$1.45M Buy
159,083
+16,731
+12% +$146K 0.02% 734
2022
Q3 		$1.15M Sell
142,352
-386,861
-73% -$3.42M 0.01% 926
2022
Q2 		$3.98M Sell
529,213
-26,212
-5% -$228K 0.04% 380
2022
Q1 		$5.21M Sell
555,425
-280,872
-34% -$2.34M 0.04% 402
2021
Q4 		$6.7M Sell
836,297
-41,177
-5% -$372K 0.04% 380
2021
Q3 		$8.55M Sell
877,474
-399,704
-31% -$3.74M 0.04% 318
2021
Q2 		$12.6M Sell
1,277,178
-173,849
-12% -$1.84M 0.06% 279
2021
Q1 		$16.7M Buy
1,451,027
+250,376
+21% +$2.87M 0.09% 204
2020
Q4 		$11.6M Buy
1,200,651
+248,174
+26% +$2.38M 0.06% 235
2020
Q3 		$8.58M Buy
952,477
+565,238
+146% +$5.98M 0.05% 221
2020
Q2 		$4.78M Buy
387,239
+131,450
+51% +$1.49M 0.04% 369
2020
Q1 		$2.3M Sell
255,789
-723,383
-74% -$7.41M 0.02% 723
2019
Q4 		$9.6M Buy
979,172
+609,480
+165% +$5.44M 0.09% 201
2019
Q3 		$2.54M Sell
369,692
-95,930
-21% -$735K 0.02% 798
2019
Q2 		$4.3M Buy
465,622
+354,145
+318% +$4.27M 0.03% 608
2019
Q1 		$1.75M Sell
111,477
-525,922
-83% -$9.27M 0.02% 936
2018
Q4 		$9.83M Buy
637,399
+517,417
+431% +$10.6M 0.09% 203
2018
Q3 		$2.58M Sell
119,982
-141,118
-54% -$3.28M 0.02% 972
2018
Q2 		$6.35M Buy
261,100
+148,324
+132% +$3.02M 0.06% 346
2018
Q1 		$1.93M Buy
+112,776
New +$2.2M 0.02% 902
2017
Q4 		– Sell
-598,665
Closed -$9.01M – 3620
2017
Q3 		$10.5M Buy
598,665
+83,095
+16% +$1.87M 0.09% 153
2017
Q2 		$17.1M Buy
515,570
+88,644
+21% +$2.74M 0.15% 132
2017
Q1 		$13.7M Buy
426,926
+143,646
+51% +$4.9M 0.12% 155
2016
Q4 		$10.3M Buy
283,280
+130,216
+85% +$5.2M 0.09% 228
2016
Q3 		$7.04M Sell
153,064
-142,205
-48% -$7.42M 0.07% 254
2016
Q2 		$14.8M Buy
295,269
+220,436
+295% +$11.7M 0.11% 152
2016
Q1 		$4M Buy
+74,833
New +$4.39M 0.03% 475
2015
Q4 		– Sell
-208,003
Closed -$12.9M – 2981
2015
Q3 		$3.87M Buy
208,003
+151,100
+266% +$9.8M 0.02% 444
2015
Q2 		$3.36M Buy
56,903
+14,947
+36% +$922K 0.02% 507
2015
Q1 		$2.61M Sell
41,956
-41,722
-50% -$2.43M 0.02% 693
2014
Q4 		$4.81M Sell
83,678
-862,679
-91% -$48.1M 0.02% 619
2014
Q3 		$50.9M Sell
946,357
-77,289
-8% -$4.09M 0.3% 69
2014
Q2 		$53.7M Buy
1,023,646
+924,538
+933% +$47.3M 0.31% 65
2014
Q1 		$5.24M Sell
99,108
-15,930
-14% -$736K 0.02% 631
2013
Q4 		$4.61M Sell
115,038
-18,766
-14% -$739K 0.02% 678
2013
Q3 		$5.05M Buy
133,804
+13,682
+11% +$534K 0.02% 612
2013
Q2 		$4.71M Buy
+120,122
New +$4.68M 0.02% 591

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

SG Americas Securities's TEVA Position: Q2 2026 in Review

SG Americas Securities increased its Teva Pharmaceuticals (TEVA) stake by 64% in Q2 2026, buying an estimated $16.7M and bringing the position to 1,282,256 shares worth $43.4M. The position accounts for 0.02% of the portfolio, ranked #382.

SG Americas Securities first reported a position in TEVA in Q2 2013 and has held it in 51 quarters since. The position peaked at $53.7M in Q2 2014. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • SG Americas Securities held 1,282,256 shares of Teva Pharmaceuticals worth $43.4M as of Q2 2026.
  • SG Americas Securities bought 501,738 Teva Pharmaceuticals shares in Q2 2026, an estimated $16.7M.
  • Teva Pharmaceuticals made up 0.02% of SG Americas Securities's portfolio in Q2 2026, its #382 holding.
  • SG Americas Securities first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 51 quarters since.
  • SG Americas Securities's Teva Pharmaceuticals position peaked at $53.7M in Q2 2014.
  • 672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.